What happened
ST Pharm disclosed a supply contract, worth US$66.2M, about 27.54% of its recent annual revenue, running through Nov 2027.
For context, this single contract equals about 27.54% of the company's most recent annual revenue.
| Counterparty | Disclosed |
|---|---|
| Contract value | US$66.2M |
| vs. recent revenue | 27.54% |
| Through | Nov 2027 (from Sep 2026) |
| Filed | 2026-09-18, Supply contract signed |
| Source | DART rcept 20260918900224 → open original filing |
Read the full filing in English
ST Pharm / Conclusion of Exclusive Sales and Supply Contract / (2026.09.18)
Conclusion of Exclusive Sales and Supply Contract
1. Sales and Supply Contract Details Supply of oligonucleotide therapeutic raw pharmaceutical materials
2. Contract Details Conditional Contract Status: Not applicable Confirmed Contract Amount: 91,332,435,000 won Conditional Contract Amount: - Total Contract Amount (KRW): 91,332,435,000 Most Recent Sales Revenue (KRW): 331,681,282,447 Percentage of Sales Revenue: 27.54%
3. Contracting Party Global Biotech company based in the United States Most Recent Sales Revenue (KRW): - Principal Business: New drug development Relationship with Company: - Performance of Similar Contracts with Company in Past 3 Years: Applicable
4. Sales and Supply Region United States, Europe, and others
5. Contract Period Start Date: 2026-09-18 End Date: 2027-11-22
6. Principal Contract Terms Deposit/Advance Payment: None Payment Terms and Conditions: -
7. Sales and Supply Method In-house Production: Applicable Outsourced Production: Not applicable Other: -
8. Contract (Order) Date 2026-09-18
9. Disclosure Reservation Reservation Period: 2027-11-22 Reason for Reservation: Request by contracting party for confidentiality of transaction
10. Other Matters for Reference in Investment Decisions - The foreign currency amount of the above contract is USD 66,135,000, and the Korean won amount is calculated by applying the KEB Hana Bank final announced exchange rate of 1,381.0 won/USD as of the previous business day (2026.09.17). - The above most recent sales revenue is based on consolidated sales for the year 2025. - The start date and contract (order) date of the above contract period are the dates on which the purchase order was received from the contracting party. - The above contract amount and contract period may be subject to change at the request of the contracting party or other reasons.
※ Related Disclosures: -
Source: DART. Information only, not investment advice.